These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20595227)

  • 21. A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells.
    Acencio MM; Puka J; Marchi E; Antonangelo L; Terra RM; Vargas FS; Capelozzi VL; Teixeira LR
    J Transl Med; 2015 Sep; 13():302. PubMed ID: 26373420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy.
    Xiang Z; Deng X; He W; Yang Q; Ni L; Dehghan Shasaltaneh M; Maghsoudloo M; Yang G; Wu J; Imani S; Wen Q
    Ann Med; 2022 Dec; 54(1):1357-1371. PubMed ID: 35543207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sulindac analogue is effective against malignant pleural effusion in mice.
    Moschos C; Psallidas I; Cottin T; Kollintza A; Papiris S; Roussos C; Stathopoulos GT; Giannis A; Kalomenidis I
    Lung Cancer; 2011 Aug; 73(2):171-5. PubMed ID: 21227533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment of a malignant pleural effusion mouse model with Lewis lung carcinoma cell lines expressing enhanced green fluorescent protein].
    Ma X; Sun Y; Wang S; Yang Z; Song Y
    Zhongguo Fei Ai Za Zhi; 2012 Jun; 15(6):317-23. PubMed ID: 22681917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion.
    Fang F; Chen P; Wu X; Yang L; Yang X; Xi ZX; Zhou BW; Zhou XK; Qian ZY; Xiao B; Wei YQ
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1149-57. PubMed ID: 19219619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
    Kang MQ; Cao YP; Deng F
    Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutical effects of pleural injecting recombinant human endostain to 
malignant pleural effusion nude mice model].
    Zhou M; Li M; Yang H; Hu C
    Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Regulation of Toll-Like Receptor 2 Engagement on CD4
    Wu XZ; Zhou Q; Lin H; Zhai K; Wang XJ; Yang WB; Shi HZ
    Am J Respir Cell Mol Biol; 2017 Mar; 56(3):342-352. PubMed ID: 27767332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Endostar combined with angiopoietin-2 inhibitor on malignant pleural effusion in mice.
    Fang SC; Zhang HT; Hu HD; Wang CY; Zhang YM
    Med Oncol; 2015 Jan; 32(1):410. PubMed ID: 25479942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
    Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
    Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
    Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
    Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.
    Stathopoulos GT; Zhu Z; Everhart MB; Kalomenidis I; Lawson WE; Bilaceroglu S; Peterson TE; Mitchell D; Yull FE; Light RW; Blackwell TS
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):142-50. PubMed ID: 16210694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of B7-H4 expression in metastatic pleural adenocarcinoma and therapeutic potential of its antagonists.
    Chen C; Qu QX; Xie F; Zhu WD; Zhu YH; Huang JA
    BMC Cancer; 2017 Sep; 17(1):652. PubMed ID: 28923053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant KRAS promotes malignant pleural effusion formation.
    Agalioti T; Giannou AD; Krontira AC; Kanellakis NI; Kati D; Vreka M; Pepe M; Spella M; Lilis I; Zazara DE; Nikolouli E; Spiropoulou N; Papadakis A; Papadia K; Voulgaridis A; Harokopos V; Stamou P; Meiners S; Eickelberg O; Snyder LA; Antimisiaris SG; Kardamakis D; Psallidas I; Marazioti A; Stathopoulos GT
    Nat Commun; 2017 May; 8():15205. PubMed ID: 28508873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 4 signaling inhibits malignant pleural effusion by altering Th1/Th17 responses.
    Xu QQ; Zhou Q; Xu LL; Lin H; Wang XJ; Ma WL; Zhai K; Tong ZH; Su Y; Shi HZ
    Cell Biol Int; 2015 Oct; 39(10):1120-30. PubMed ID: 25939739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recruitment of IL-1β-producing intermediate monocytes enhanced by C5a contributes to the development of malignant pleural effusion.
    Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Li X; Feng J
    Thorac Cancer; 2022 Mar; 13(6):811-823. PubMed ID: 35137541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.
    Ye ZJ; Zhou Q; Yin W; Yuan ML; Yang WB; Xiong XZ; Zhang JC; Shi HZ
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1168-79. PubMed ID: 23065014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
    Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
    Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4
    Niu Y; Ye L; Peng W; Wang Z; Wei X; Wang X; Li Y; Zhang S; Xiang X; Zhou Q
    J Leukoc Biol; 2021 Jul; 110(1):39-52. PubMed ID: 33847412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.